| Safety and Efficacy Study of the Amaranth Medical MAGNITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT III) (NCT02900937) | Amaranth Medical Inc. | 2016-10-01 |
| Probiotics and Corticosteroids for Treating Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adenitis (PFAPA) (NCT02535962) | Connecticut Children's Medical Center | 2016-10-01 |
| Safety and Tolerability Evaluation Study of BVAC-C in Patients With HPV Type 16 or 18 Positive Cervical Cancer (NCT02866006) | Cellid Co., Ltd. | 2016-10-01 |
| Study of the Safety, Efficacy and PK of EYN-1601 in Dilation of the Pupil (NCT02946125) | Eyenovia Inc. | 2016-10-01 |
| A Study of Pemetrexed Plus Cisplatin With Concurrent Radiation Therapy Followed by Docetaxel Consolidation in Patients With Inoperable Squamous Cell Lung Cancer (NCT02787473) | First People's Hospital of Hangzhou | 2016-10-01 |
| Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial (NCT02784392) | Lyric Pharmaceuticals | 2016-10-01 |
| the Effect of Cerebrolysin on Physical and Mental Functions of Down Syndrome (NCT04751136) | Mansoura University Children Hospital | 2016-09-30 |
| Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast Cancer (NCT02778685) | City of Hope Medical Center | 2016-09-30 |
| Study of Pembrolizumab (MK-3475) Monotherapy in Locally Advanced/Metastatic Renal Cell Carcinoma (MK-3475-427/KEYNOTE-427) (NCT02853344) | Merck Sharp & Dohme LLC | 2016-09-30 |
| A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia (NCT02723994) | Incyte Corporation | 2016-09-30 |
| A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes (NCT02769091) | Teva Branded Pharmaceutical Products R&D, Inc. | 2016-09-30 |
| CPC-201 Alzheimer's Disease Type Dementia: PET Study (NCT02860065) | Chase Pharmaceuticals Corporation, an affiliate of Allergan plc | 2016-09-30 |
| Long-Term Side Effects of Ruxolitinib in Treating Patients With Myelofibrosis (NCT02784496) | M.D. Anderson Cancer Center | 2016-09-29 |
| Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimod in Subjects With Symptomatic Chronic GVHD (NCT02461134) | Actelion | 2016-09-29 |
| Study of Safety and Efficacy of KTE-C19 in Combination With Atezolizumab in Adults With Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (NCT02926833) | Kite, A Gilead Company | 2016-09-29 |
| Efficacy and Safety of SCM-CGH in Patients With Steroid-Refractory or Dependent Chronic Graft-Versus-Host Disease (NCT04189432) | SCM Lifescience Co., LTD. | 2016-09-28 |
| Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL) (NCT02910583) | Pharmacyclics LLC. | 2016-09-28 |
| Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations (NCT02795156) | SCRI Development Innovations, LLC | 2016-09-28 |
| Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease (NCT02927184) | Viking Therapeutics, Inc. | 2016-09-28 |
| Lymphodepletion and Anti-PD-1 Blockade to Reduce Relapse in AML Patient Not Eligible for Transplant (NCT02771197) | Northside Hospital, Inc. | 2016-09-28 |
| Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients (NCT03094845) | ASIT Biotech S.A. | 2016-09-28 |
| Study of the Efficacy and Safety of Initial Administration of 17 mg Vortioxetine Intravenously With 10 mg/Day Vortioxetine Orally in Patients With Major Depressive Disorder (NCT02919501) | H. Lundbeck A/S | 2016-09-27 |
| LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer (NCT02612194) | Wake Forest University Health Sciences | 2016-09-27 |
| Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for Melanoma (NCT04062032) | University of Utah | 2016-09-27 |
| CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis (NCT02629419) | Matinas BioPharma Nanotechnologies, Inc. | 2016-09-27 |
| A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Locally Advanced or Metastatic Breast Cancer (BC) Who Received Prior Trastuzumab and Taxane Based Therapy (NCT02924883) | Hoffmann-La Roche | 2016-09-26 |
| A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC) (NCT02819635) | AbbVie | 2016-09-26 |
| Apixaban in End-stage Kidney Disease : A Pharmacokinetics Study (NCT03456648) | Universitaire Ziekenhuizen KU Leuven | 2016-09-25 |
| Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients (NCT02755844) | Hospices Civils de Lyon | 2016-09-23 |
| Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients (NCT02919111) | University of California, San Francisco | 2016-09-23 |
| Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors (NCT02709889) | AbbVie | 2016-09-23 |
| Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery (NCT02738606) | M.D. Anderson Cancer Center | 2016-09-23 |
| A Phase 2a Study to Evaluate the Effects of Sirukumab in Subjects With Severe Poorly Controlled Asthma (NCT02794519) | GlaxoSmithKline | 2016-09-23 |
| A Study of Atezolizumab as First-line Monotherapy for Advanced or Metastatic Non-Small Cell Lung Cancer (NCT02848651) | Genentech, Inc. | 2016-09-23 |
| Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms (NCT02756572) | University of Washington | 2016-09-22 |
| Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer (NCT02689427) | M.D. Anderson Cancer Center | 2016-09-22 |
| Buprenorphine Transdermal Patches in Arthroscopic Rotator Cuff Repair (NCT03380533) | Hospital Italiano de Buenos Aires | 2016-09-22 |
| A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma (NCT02805179) | University of Michigan Rogel Cancer Center | 2016-09-22 |
| A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101) (NCT02018861) | Incyte Corporation | 2016-09-22 |
| Effect of Lidocaine With Magnesium Sulfate on the Success of the Inferior Alveolar Nerve Block (NCT03262857) | Isfahan University of Medical Sciences | 2016-09-21 |
| 18F-Fluorocholine for the Detection of Parathyroid Adenomas (NCT03764007) | Thomas Hope | 2016-09-21 |
| Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children With Human Immunodeficiency Virus-1 (NCT02881320) | Gilead Sciences | 2016-09-21 |
| Elotuzumab, Lenalidomide and Dexamethasone in Treatment of Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients (NCT02843074) | SCRI Development Innovations, LLC | 2016-09-21 |
| Safety, Tolerability, and Efficacy of GS-9876 in Participants With Active Rheumatoid Arthritis on Background Therapy With Methotrexate (NCT02885181) | Gilead Sciences | 2016-09-21 |
| A Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells in Patients With Knee Osteoarthritis (NCT02838069) | University Hospital, Montpellier | 2016-09-20 |
| Immunomodulatory Effects of IVIg on Pregnancy Rate of Patient With Recurrent Pregnancy Loss (NCT03174951) | Tabriz University of Medical Sciences | 2016-09-20 |
| Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM (NCT02436733) | European Organisation for Research and Treatment of Cancer - EORTC | 2016-09-20 |
| Treg Therapy in Subclinical Inflammation in Kidney Transplantation (NCT02711826) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-09-20 |
| A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma (NCT02918019) | Hoffmann-La Roche | 2016-09-20 |
| A Biomarker-Directed Phase 2 Trial of Tamibarotene (SY-1425) in Participants With Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT02807558) | Syros Pharmaceuticals | 2016-09-20 |
| A Safety and Efficacy Study of CC-122 in Combination With Nivolumab in Subjects With Unresectable Hepatocellular Carcinoma (HCC) (NCT02859324) | Celgene | 2016-09-20 |
| The Correlate of Risk Targeted Intervention Study (NCT02735590) | University of Cape Town | 2016-09-20 |
| Study Evaluating the Effects of Toradol and Lyrica for Pain Control After Donor Nephrectomy (NCT03669081) | University of Utah | 2016-09-20 |
| ODYSSEY (PENTA 20) (NCT02259127) | PENTA Foundation | 2016-09-20 |
| Study of Ibrutinib in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed/Relapsed and Refractory Multiple Myeloma (NCT02902965) | Pharmacyclics Switzerland GmbH | 2016-09-20 |
| XC8 in the Treatment of Patients With Bronchial Asthma (NCT03450434) | PHARMENTERPRISES LLC | 2016-09-20 |
| Chemoprevention of Gastric Carcinogenesis (NCT02794428) | Vanderbilt-Ingram Cancer Center | 2016-09-19 |
| Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002) (NCT02663622) | Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2016-09-19 |
| Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis (NCT02743364) | National Cancer Institute (NCI) | 2016-09-19 |
| Efficacy, Safety and Dose Finding Trial of Topical Jaungo Application in Atopic Dermatitis Patients (NCT02900131) | Kyung Hee University Hospital at Gangdong | 2016-09-19 |
| Premedication With Alprazolam and Midazolam for Upper Gastrointestinal Endoscopy (NCT03130842) | Isfahan University of Medical Sciences | 2016-09-17 |
| Mgt of Chronic Subdural Hematoma Using Dexamethasone (NCT02938468) | University of Calgary | 2016-09-17 |
| Photodynamic Therapy for Benign Dermal Neurofibromas- Phase II (NCT02728388) | Donald Basel | 2016-09-16 |
| Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole (NCT03038308) | Columbia University | 2016-09-16 |
| A Study to Evaluate the Efficacy and Safety of ASP1707 in Postmenopausal Female Patients With Rheumatoid Arthritis Taking Methotrexate (NCT02884635) | Astellas Pharma Inc | 2016-09-16 |
| Pembrolizumab, Lenalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant (NCT02880228) | Mayo Clinic | 2016-09-16 |
| Palbociclib and FES PET (NCT02806050) | University Medical Center Groningen | 2016-09-16 |
| Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Cancer (NCT03073785) | University of Nebraska | 2016-09-16 |
| Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Participants With Chronic Hepatitis B Virus (HBV) Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver Transplant (NCT02862548) | Gilead Sciences | 2016-09-16 |
| Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer (NCT02728258) | NRG Oncology | 2016-09-16 |
| Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus (NCT02871882) | Mayo Clinic | 2016-09-15 |
| Pembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Small Cell Lung Cancer (NCT02879994) | Jonsson Comprehensive Cancer Center | 2016-09-15 |
| Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence (NCT02918357) | University of California, San Francisco | 2016-09-15 |
| Pharmacogenetics of Naltrexone for Stimulant Abuse (NCT03226223) | New York State Psychiatric Institute | 2016-09-15 |
| Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases (NCT02595905) | National Cancer Institute (NCI) | 2016-09-15 |
| An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE (NCT02633293) | United Therapeutics | 2016-09-15 |
| An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (NCT02890992) | Sanofi | 2016-09-15 |
| Use of Sildenafil Citrate in Management of Mild Pre-eclampsia (NCT03262961) | Assiut University | 2016-09-15 |
| Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer (NCT02865811) | Dana-Farber Cancer Institute | 2016-09-15 |
| A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease (NCT02841995) | Kadmon, a Sanofi Company | 2016-09-15 |
| Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma (NCT01775475) | AIDS Malignancy Consortium | 2016-09-15 |
| Study to Evaluate Efficacy, Safety and Tolerability of JTE-051 in Subjects With Active Rheumatoid Arthritis (NCT02919475) | Akros Pharma Inc. | 2016-09-14 |
| A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis (NCT02852967) | Kadmon Corporation, LLC | 2016-09-14 |
| A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer (NCT02747004) | Eli Lilly and Company | 2016-09-14 |
| Tocotrienol in Combination With Neoadjuvant Chemotherapy for Women With Breast Cancer (NCT02909751) | Vejle Hospital | 2016-09-14 |
| A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH (NCT02784444) | Cirius Therapeutics, Inc. | 2016-09-14 |
| A Study of the Effects of ALKS 4230 (Nemvaleukin Alfa) on Subjects With Solid Tumors (NCT02799095) | Mural Oncology, Inc | 2016-09-14 |
| Posthemorrhoidectomy Pain Management With Electronic Bidet or Sitz Bath (NCT02353156) | Seoul National University Hospital | 2016-09-14 |
| A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis (NCT02899988) | Eli Lilly and Company | 2016-09-14 |
| Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers (NCT02749903) | Alliance for Clinical Trials in Oncology | 2016-09-14 |
| [18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer (NCT02695628) | Stanford University | 2016-09-13 |
| A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy (NCT02942381) | Peking University First Hospital | 2016-09-13 |
| A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers (NCT02910726) | Memorial Sloan Kettering Cancer Center | 2016-09-13 |
| Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel (NCT02684461) | UNC Lineberger Comprehensive Cancer Center | 2016-09-13 |
| Influence of Triflusal on Cognitive Functions in Subjects Under Chronic Stress (NCT02904109) | Prof. Dominique de Quervain, MD | 2016-09-13 |
| Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION) (NCT02864992) | EMD Serono Research & Development Institute, Inc. | 2016-09-13 |
| Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment (NCT02754752) | M.D. Anderson Cancer Center | 2016-09-13 |
| Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE) (NCT02080195) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-09-13 |
| Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of COR-001 (NCT02868229) | Novo Nordisk A/S | 2016-09-12 |
| MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors (NCT02669914) | Washington University School of Medicine | 2016-09-12 |